A phase I first-in-human clinical trial of CD19-targeted 19-28z/4-1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter's transformation Meeting Abstract


Authors: Park, J. H.; Palomba, M. L.; Batlevi, C. L.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R. R.; Bernal, Y.; Hall, M.; Pineda, J.; Diamonte, C.; Halton, E.; Brentjens, R. J.; Sadelain, M.
Abstract Title: A phase I first-in-human clinical trial of CD19-targeted 19-28z/4-1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter's transformation
Meeting Title: 60th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 132
Issue: Suppl. 1
Meeting Dates: 2018 Dec 1-4
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2018-11-29
Language: English
ACCESSION: WOS:000454837600278
PROVIDER: wos
DOI: 10.1182/blood-2018-99-117737
Notes: Meeting Abstract: 224 -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Renier J Brentjens
    236 Brentjens
  2. Maria Lia Palomba
    170 Palomba
  3. Jae Hong Park
    182 Park
  4. Elizabeth F Halton
    35 Halton
  5. Michel W J Sadelain
    491 Sadelain
  6. Isabelle C Riviere
    192 Riviere
  7. Xiuyan Wang
    87 Wang
  8. Yvette J Bernal
    29 Bernal
  9. Connie Wing-Ching Lee
    73 Lee
  10. Malloury W Hall
    4 Hall
  11. John Pineda
    6 Pineda
Related MSK Work